Comparison Maze Therapeutics (MAZE) with Competitors
Maze Therapeutics (MAZE) industry is Biotechnology.
Operating Margin
MAZE-132.80%
Industry-2055.25%
Upside+1922.45%
Debt-to-Equity
MAZE11.36%
Industry28.27%
Upside-59.80%
Free Cash Flow Yield
MAZE-8.35%
Industry-1.75%
Upside-6.61%
P/E
MAZE-11.39
Industry-20.52
Upside+913.13%
Forward P/E
MAZE8.53
Industry16.33
Upside-47.77%
P/S
MAZE81.33
Industry10.01
Upside+712.20%
P/B
MAZE4.84
Industry5.15
Upside-5.94%